Cetera Investment Advisers
AVXL icon

Cetera Investment Advisers’s Anavex Life Sciences AVXL Stock Holding History

Cetera Investment Advisers’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195K Buy
75,121
+20,984
+39% +$62.1K ﹤0.01% 4502
2026
Q1 		$166K Buy
54,137
+11,281
+26% +$48.9K ﹤0.01% 4333
2025
Q4 		$153K Buy
42,856
+14,598
+52% +$89.4K ﹤0.01% 4296
2025
Q3 		$251K Buy
28,258
+12,436
+79% +$126K ﹤0.01% 3982
2025
Q2 		$146K Sell
15,822
-4,237
-21% -$36.2K ﹤0.01% 3808
2025
Q1 		$172K Buy
20,059
+6,058
+43% +$57.2K ﹤0.01% 3651
2024
Q4 		$150K Buy
+14,001
New +$108K ﹤0.01% 3504

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cetera Investment Advisers's AVXL Position: Q2 2026 in Review

Cetera Investment Advisers increased its Anavex Life Sciences (AVXL) stake by 39% in Q2 2026, buying an estimated $62.1K and bringing the position to 75,121 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #4502.

Cetera Investment Advisers first reported a position in AVXL in Q4 2024 and has held it in 7 quarters since. The position peaked at $251K in Q3 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Cetera Investment Advisers held 75,121 shares of Anavex Life Sciences worth $195K as of Q2 2026.
  • Cetera Investment Advisers bought 20,984 Anavex Life Sciences shares in Q2 2026, an estimated $62.1K.
  • Anavex Life Sciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4502 holding.
  • Cetera Investment Advisers first reported a position in Anavex Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • Cetera Investment Advisers's Anavex Life Sciences position peaked at $251K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.